Fundraising Fox
Latus Bio
5 known investors
Find your way into Latus Bio
Sign up to see every warm intro you have to Latus Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Latus Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Latus develops gene therapies based on novel AAV capsid variants matched to optimized routes of administration, aiming to target specific cell types and tissues to lower dose requirements, toxicity, and manufacturing costs. It focuses on treating monogenic diseases affecting the central nervous system and peripheral tissues using computational methods and unbiased capsid screening.
Investors · 5
How we know: 8VC's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: BioAdvance's portfolio page · Not right? Tell us
How we know: DCVC (Data Collective)'s portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
__Twitter.png)
Funding
SEC filings, press & company announcements$97M disclosed across 1 round · 2026
- $97MraisedMay 2026 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Latus Bio do?
- Latus develops gene therapies based on novel AAV capsid variants matched to optimized routes of administration, aiming to target specific cell types and tissues to lower dose requirements, toxicity, and manufacturing costs. It focuses on treating monogenic diseases affecting the central nervous system and peripheral tissues using computational methods and unbiased capsid screening.
- Who are Latus Bio's investors?
- Latus Bio's investors include 8VC, BioAdvance, DCVC (Data Collective), Gaingels, Modi Ventures.
- How much funding has Latus Bio raised?
- Latus Bio has disclosed $97M raised across 1 round.